- Home
- DGICA vs FLGT Comparison
DGICA vs FLGT Comparison
Compare DGICA & FLGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DGICA | FLGT |
|---|---|---|
| Founded | 1986 | 2011 |
| Country | United States | United States |
| Employees | 851 | N/A |
| Industry | Property-Casualty Insurers | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 607.2M | 525.3M |
| IPO Year | N/A | 2016 |
Fundamental Metrics
Financial Performance| Metric | DGICA | FLGT |
|---|---|---|
| Price | $16.21 | $15.12 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 3 |
| Target Price | $19.00 | ★ $28.33 |
| AVG Volume (30 Days) | 80.9K | ★ 442.6K |
| Earning Date | 04-30-2026 | 05-01-2026 |
| Dividend Yield | ★ 4.14% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $18,730,000.00 |
| Revenue This Year | $2.26 | $10.09 |
| Revenue Next Year | N/A | $12.18 |
| P/E Ratio | $7.82 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $16.29 | $13.46 |
| 52 Week High | $21.06 | $31.04 |
Technical Indicators
Market Signals| Indicator | DGICA | FLGT |
|---|---|---|
| Relative Strength Index (RSI) | 36.01 | 43.47 |
| Support Level | N/A | $14.23 |
| Resistance Level | $17.75 | $16.70 |
| Average True Range (ATR) | 0.39 | 0.63 |
| MACD | -0.11 | -0.04 |
| Stochastic Oscillator | 20.47 | 43.55 |
Price Performance
Historical ComparisonAbout DGICA Donegal Group Inc.
Donegal Group Inc is an insurance holding company whose insurance subsidiaries and affiliates offer property and casualty insurance in 21 Mid-Atlantic, Midwestern, Southern, and Southwestern states. It includes three segments: Investments Function, Commercial Lines of Insurance, and Personal Lines of Insurance. The majority of revenue is from the commercial Lines segment. The commercial Lines segment consists mainly of commercial automobile, commercial multi-peril, and workers' compensation policies.
About FLGT Fulgent Genetics Inc.
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in the laboratory services business and the therapeutic development business. The laboratory services business, which generates key revenue, includes technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue, and Foreign.